PROCEPT BioRobotics Corp (PRCT)
60.10
-0.51
(-0.84%)
USD |
NASDAQ |
May 02, 14:06
PROCEPT BioRobotics Cash from Financing (TTM): 167.80M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 167.80M |
| September 30, 2023 | 163.61M |
| June 30, 2023 | 2.269M |
| March 31, 2023 | 2.701M |
| December 31, 2022 | 3.612M |
| Date | Value |
|---|---|
| September 30, 2022 | 5.574M |
| June 30, 2022 | 178.92M |
| March 31, 2022 | 262.18M |
| December 31, 2021 | 262.12M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.269M
Minimum
Jun 2023
262.18M
Maximum
Mar 2022
116.53M
Average
163.61M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
| Globus Medical Inc | -231.82M |
| Glaukos Corp | 15.04M |
| Integra Lifesciences Holdings Corp | -229.92M |
| Intuitive Surgical Inc | 46.90M |
| Masimo Corp | -57.10M |